Your session is about to expire
← Back to Search
Early Alimentation After Colorectal Surgery
Phase 3
Waitlist Available
Research Sponsored by Maisonneuve-Rosemont Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Class ASA (American Society of Anaesthesiology) I, II or III, +/- E
Patient who will undergo elective or urgent colic resection using laparoscopy or opened surgery defined in section B
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is testing whether starting oral food earlier after colorectal surgery can shorten hospital stays.
Who is the study for?
This trial is for adults over 18 with Crohn's Disease or Colorectal Cancer, undergoing colorectal surgery. They must be in stable condition (ASA class I-III), willing to participate, and able to consent. Excluded are those with recent infections, certain intra-surgery complications, severe systemic disease (ASA IV-V), pregnancy, chemotherapy within the last month, or previous radiation near the anastomosis site.Check my eligibility
What is being tested?
The study examines if starting oral feeding early after colorectal surgery is beneficial compared to waiting for intestinal function return. It aims to see if this can shorten hospital stays. Participants will either begin eating soon after surgery or follow traditional dietary protocols based on bowel recovery.See study design
What are the potential side effects?
Since this trial involves a change in diet following surgery rather than medication, side effects may include gastrointestinal discomfort such as nausea or bloating due to early feeding versus delayed alimentation according to standard care.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My health is good to moderately impaired according to ASA standards.
Select...
I am scheduled for a surgery to remove part of my colon.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Hospitalisation stay measured in days
Secondary outcome measures
Gastro-intestinal signs and symptoms
Post-surgery complications
Treatment of gastro-intestinal signs and symptoms
Find a Location
Who is running the clinical trial?
Maisonneuve-Rosemont HospitalLead Sponsor
99 Previous Clinical Trials
35,523 Total Patients Enrolled
Pierre Dubé, MDStudy ChairMaisonneuve-Rosemont Hospital
1 Previous Clinical Trials
50 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My health is good to moderately impaired according to ASA standards.I had an accidental cut in my small intestine during surgery.I am willing to participate in the study.I still have cancer cells in my abdomen after surgery.I am scheduled for a surgery to remove part of my colon.I am in a very serious health condition.I have a diagnosed issue with my digestive system moving food.I have not had a severe infection in the last 10 days.I have not had chemotherapy in the last 4 weeks before surgery.I had surgery on my small intestine that did not involve the colon.I received chemotherapy in my abdomen during or after surgery.I have had radiation near where my surgery will connect tissues.I had surgery for a blockage in my belly along with another major belly surgery.I need a procedure to drain my stomach after surgery.I am 18 years old or older.I have had surgery to connect my colon or ileum to my anus.I needed a naso-gastric tube after surgery due to changes in my condition.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 2 awards, including:- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this research involve testing on elderly individuals?
"The age limit for this particular study is 18+. However, there are a total of 99 clinical trials available for minors and 1078 studies open to patients that are 65 years or older."
Answered by AI
Are there any participants needed for this test currently?
"According to the listing on clinicaltrials.gov, this study is not currently seeking patients for participation. This particular trial was first posted on January 1st, 2006 and updated April 6th of that same year. There are 1152 other trials which are actively recruiting participants."
Answered by AI
Could I qualify to be a part of this research project?
"Eligible participants for this clinical trial must have ileocolitis and be between 18 to 0 years old. A total of 800 patients are being recruited by the study."
Answered by AI
Has this medication been green-lit by the FDA?
"The safety of this treatment was given a score of three. This is because the trial is in its third phase, so there is some evidence to suggest that it is effective as well as multiple rounds of data supporting its safety."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger